Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
354.91
-1.90 (-0.53%)
Streaming Delayed Price
Updated: 9:56 AM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,670
Open
355.17
Bid (Size)
354.22 (20)
Ask (Size)
355.63 (20)
Prev. Close
356.81
Today's Range
354.02 - 355.96
52wk Range
208.62 - 366.08
Shares Outstanding
44,891,523
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Look Into United Therapeutics Inc's Price Over Earnings
October 03, 2024
Via
Benzinga
U.S. Stock: United Therapeutics Corp
September 25, 2024
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease.
Via
Talk Markets
Performance
YTD
+56.11%
+56.11%
1 Month
+1.78%
+1.78%
3 Month
+7.79%
+7.79%
6 Month
+49.25%
+49.25%
1 Year
+54.09%
+54.09%
More News
Read More
Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today
September 24, 2024
Via
Benzinga
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
September 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
Key Takeaways From United Therapeutics Analyst Ratings
September 23, 2024
Via
Benzinga
The Analyst Verdict: United Therapeutics In The Eyes Of 8 Experts
August 20, 2024
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
August 05, 2024
Via
Benzinga
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
September 10, 2024
From
United Therapeutics Corporation
Via
Business Wire
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
Via
Benzinga
Exposures
Product Safety
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
September 05, 2024
Via
Investor's Business Daily
Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
August 29, 2024
Via
Investor's Business Daily
Ambarella To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Wednesday
August 28, 2024
Via
Benzinga
United Therapeutics Corporation to Present at Upcoming Investor Conferences
August 28, 2024
From
United Therapeutics Corporation
Via
Business Wire
Biohaven Stock Earns Relative Strength Rating Upgrade
August 21, 2024
Via
Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
August 21, 2024
Via
Investor's Business Daily
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
August 19, 2024
Via
Benzinga
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
August 19, 2024
Via
Investor's Business Daily
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
August 18, 2024
Via
Benzinga
NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
August 15, 2024
Via
Chartmill
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Via
InvestorPlace
UTHR Stock Earnings: United Therapeutics Misses EPS, Beats Revenue for Q2 2024
July 31, 2024
Via
InvestorPlace
United Therapeutics Stock Skids On Mixed Second-Quarter Results
July 31, 2024
Via
Investor's Business Daily
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
July 31, 2024
From
United Therapeutics Corporation
Via
Business Wire
The 3 Best 3D Bioprinting Stocks to Buy Now
July 26, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.